A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide in Dogs with Spontaneous Activated B-Cell like Diffuse Large B-Cell Lymphoma
Nicola J. Mason(University of Pennsylvania), Albert S. Baldwin(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II
|Journal of Biological Chemistry|2000|449
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
|Genes & Development|1998|402
NF-κB and IKK as therapeutic targets in cancer
|Cell Death and Differentiation|2006|393
Positive and negative regulation of EAAT2 by NF‐κB: a role for N‐myc in TNFα‐controlled repression
|The EMBO Journal|2005|234